130 related articles for article (PubMed ID: 16892907)
1. Evaluation of the indirect effects of a pneumococcal vaccine in a community-randomized study.
Moulton LH; O'Brien KL; Reid R; Weatherholtz R; Santosham M; Siber GR
J Biopharm Stat; 2006; 16(4):453-62. PubMed ID: 16892907
[TBL] [Abstract][Full Text] [Related]
2. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).
Isaacman DJ; Fletcher MA; Fritzell B; Ciuryla V; Schranz J
Vaccine; 2007 Mar; 25(13):2420-7. PubMed ID: 17049677
[TBL] [Abstract][Full Text] [Related]
3. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
[TBL] [Abstract][Full Text] [Related]
4. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
[TBL] [Abstract][Full Text] [Related]
5. [Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain].
Blanco Quirós A; Giménez Sánchez F; Asensi Botet F; Bernaola Iturbe E; Martín Fde J; García Pérez J; Garcés Sánchez M; Gómez Campderá JA; Picazo JJ; Pineda Solas V;
An Esp Pediatr; 2002 Oct; 57(4):287-9. PubMed ID: 12392660
[No Abstract] [Full Text] [Related]
6. Reduction of carriage and transmission of Streptococcus pneumoniae: the beneficial "side effect" of pneumococcal conjugate vaccine.
Azzari C; Resti M
Clin Infect Dis; 2008 Oct; 47(8):997-9. PubMed ID: 18781870
[No Abstract] [Full Text] [Related]
7. Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants.
O'Brien KL; David AB; Chandran A; Moulton LH; Reid R; Weatherholtz R; Santosham M
Pediatr Infect Dis J; 2008 Jan; 27(1):71-3. PubMed ID: 18162944
[TBL] [Abstract][Full Text] [Related]
8. Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.
Bolton M; Barson W
Pediatr Ann; 2010 Aug; 39(8):497-503. PubMed ID: 20704146
[No Abstract] [Full Text] [Related]
9. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003.
Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891
[No Abstract] [Full Text] [Related]
10. Decreasing invasive pneumococcal disease in the elderly: a state-level analysis.
McBean AM; Jung K; Hebert PL
Vaccine; 2006 Jul; 24(27-28):5609-14. PubMed ID: 16725240
[TBL] [Abstract][Full Text] [Related]
11. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial.
O'Brien KL; Millar EV; Zell ER; Bronsdon M; Weatherholtz R; Reid R; Becenti J; Kvamme S; Whitney CG; Santosham M
J Infect Dis; 2007 Oct; 196(8):1211-20. PubMed ID: 17955440
[TBL] [Abstract][Full Text] [Related]
12. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
Long SS
Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
Lloyd A; Patel N; Scott DA; Runge C; Claes C; Rose M
Eur J Health Econ; 2008 Feb; 9(1):7-15. PubMed ID: 17333089
[TBL] [Abstract][Full Text] [Related]
14. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
[TBL] [Abstract][Full Text] [Related]
15. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
Toltzis P; Jacobs MR
Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
[TBL] [Abstract][Full Text] [Related]
17. Indirect effects of childhood pneumococcal vaccination on pneumococcal carriage among adults and older children in Australian Aboriginal communities.
Mackenzie G; Carapetis J; Leach AJ; Hare K; Morris P
Vaccine; 2007 Mar; 25(13):2428-33. PubMed ID: 17030493
[TBL] [Abstract][Full Text] [Related]
18. [Pediatrics. Conjugate anti-pneumoccoccal vaccine: what are the results four years after introduction?].
Myers C; Gervaix A
Rev Med Suisse; 2005 Jan; 1(2):142, 144, 146-7. PubMed ID: 15773216
[TBL] [Abstract][Full Text] [Related]
19. [Conjugated pneumococcal vaccine: a clinical profile].
Di Virgilio R; Zollo A
Ann Ig; 2001; 13(4 Suppl 3):39-42. PubMed ID: 11760435
[No Abstract] [Full Text] [Related]
20. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?
Moore MR; Whitney CG
Clin Infect Dis; 2008 Jan; 46(2):183-5. PubMed ID: 18171248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
